ALIOTH BIOTECH (SHANGHAI) CO., LTD Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2021

Location

Shanghai China

Primary Industry

Medical Devices & Equipment

About

Established in 2021 and based in Shanghai, China, is a biotechnology and pharmaceutical company that focuses on the development and application of technology products to support pharmaceutical processes. The core team has more than 10 years of technical experience in filter applications in the pharmaceutical industry. In October 2022,it raised approximately CNY 100 million in series A funding co-led by new investor Legend Capital and Matrix Partners China. In October 2023, ALIOTH raised approximately CNY100 million in series A+ funding. The company's self-developed products such as PES (poly ether sulfones) membrane Sterilizing-grade capsule filters, PTFE (polytetrafluoroethylene) membrane sterilizing-grade capsule filters, depth filters, disposable vacuum filters, and sterile-filtration systems. Their products are used in the field of blood products, vaccines, antibodies, recombinant proteins, ADC processes, and traditional chemotherapy drugs.

Current Investors

Legend Capital, MPC, China International Capital Corporation

Request a demo to show more

Primary Industry

Medical Devices & Equipment

Sub Industries

Biotechnology, Medical Devices & Equipment

Website

www.aliothbio.com

Verticals

Manufacturing

Company Stage

Series A

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.